Pyogenic liver abscesses in peritoneal dialysis patients: A single-centre retrospective case series

Regina Shaoying Lim, Yong Pey See
{"title":"Pyogenic liver abscesses in peritoneal dialysis patients: A single-centre retrospective case series","authors":"Regina Shaoying Lim, Yong Pey See","doi":"10.1177/08968608241239798","DOIUrl":null,"url":null,"abstract":"Peritoneal dialysis (PD)-related infection rates have improved, but serious complications such as liver abscesses remain an issue, posing unique management challenges including safety of continuing PD versus early PD catheter removal. Current literature describing this is unfortunately limited. This study aims to describe the characteristics, management and outcomes of liver abscesses in PD patients from a retrospective review of prevalent PD patients on follow-up at Tan Tock Seng Hospital between 1st January 2016 and 30th June 2021. A total of 11/383 PD patients (2.9%) were treated for liver abscesses. Most were diabetic ( n =10, 90.9%), with a median PD vintage of 541 days (interquartile range: 310–931 days). Fever ( n = 7, 63.6%), bacteraemia ( n = 7, 63.6%) and concomitant PD peritonitis ( n = 7, 63.6%) were the most common presenting symptoms. Majority of patients underwent radiological aspiration of abscess in addition to antibiotics ( n = 7, 63.6%). PD catheter was removed in eight patients (72.7%), with the most common indications being empirical removal due to intra-abdominal abscess ( n = 5, 62.5%) followed by septic shock ( n = 2, 25%) and refractory PD peritonitis ( n = 1, 12.5%). Only three patients (37.5%) remained on PD, as they did not develop PD peritonitis during their course of treatment. The overall mortality remains high with three patients (27.3%) passing away within 6 months of presentation. Liver abscesses in PD patients is associated with poor technique and overall survival. Absence of PD peritonitis appears to be a good prognostic factor, but larger studies are required to guide the optimal management of liver abscesses in PD patients.","PeriodicalId":519220,"journal":{"name":"Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis","volume":"211 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/08968608241239798","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Peritoneal dialysis (PD)-related infection rates have improved, but serious complications such as liver abscesses remain an issue, posing unique management challenges including safety of continuing PD versus early PD catheter removal. Current literature describing this is unfortunately limited. This study aims to describe the characteristics, management and outcomes of liver abscesses in PD patients from a retrospective review of prevalent PD patients on follow-up at Tan Tock Seng Hospital between 1st January 2016 and 30th June 2021. A total of 11/383 PD patients (2.9%) were treated for liver abscesses. Most were diabetic ( n =10, 90.9%), with a median PD vintage of 541 days (interquartile range: 310–931 days). Fever ( n = 7, 63.6%), bacteraemia ( n = 7, 63.6%) and concomitant PD peritonitis ( n = 7, 63.6%) were the most common presenting symptoms. Majority of patients underwent radiological aspiration of abscess in addition to antibiotics ( n = 7, 63.6%). PD catheter was removed in eight patients (72.7%), with the most common indications being empirical removal due to intra-abdominal abscess ( n = 5, 62.5%) followed by septic shock ( n = 2, 25%) and refractory PD peritonitis ( n = 1, 12.5%). Only three patients (37.5%) remained on PD, as they did not develop PD peritonitis during their course of treatment. The overall mortality remains high with three patients (27.3%) passing away within 6 months of presentation. Liver abscesses in PD patients is associated with poor technique and overall survival. Absence of PD peritonitis appears to be a good prognostic factor, but larger studies are required to guide the optimal management of liver abscesses in PD patients.
腹膜透析患者的化脓性肝脓肿:单中心回顾性病例系列
与腹膜透析(PD)相关的感染率已有所改善,但肝脓肿等严重并发症仍是一个问题,这给管理带来了独特的挑战,包括继续腹膜透析与尽早拔除腹膜透析导管的安全性。遗憾的是,目前有关这方面的文献十分有限。本研究旨在通过对2016年1月1日至2021年6月30日期间在陈笃生医院接受随访的流行性腹腔镜手术患者进行回顾性审查,描述腹腔镜手术患者肝脓肿的特征、管理和结果。共有11/383名帕金森病患者(2.9%)因肝脓肿接受治疗。大多数患者为糖尿病患者(10人,占90.9%),中位病程为541天(四分位间范围:310-931天)。发热(7 例,占 63.6%)、菌血症(7 例,占 63.6%)和并发腹膜透析腹膜炎(7 例,占 63.6%)是最常见的首发症状。大多数患者在接受抗生素治疗的同时,还接受了放射学脓液抽吸术(7 例,占 63.6%)。八名患者(72.7%)拔除了腹腔穿刺导管,最常见的适应症是腹腔内脓肿导致的经验性拔管(5例,62.5%),其次是脓毒性休克(2例,25%)和难治性腹腔穿刺导管腹膜炎(1例,12.5%)。只有三名患者(37.5%)在治疗过程中未发生腹膜透析性腹膜炎,因此仍在接受腹膜透析治疗。总死亡率仍然很高,有三名患者(27.3%)在发病后 6 个月内死亡。腹膜透析患者的肝脓肿与不良的技术和总体存活率有关。没有腹膜透析腹膜炎似乎是一个良好的预后因素,但还需要更大规模的研究来指导腹膜透析患者肝脓肿的最佳治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信